Medicine and Dentistry
Surgery
100%
Neoplasm
81%
Hepatectomy
79%
Postoperative Complication
48%
Pancreaticoduodenectomy
48%
Recurrent Disease
38%
Disease
34%
Body Mass Index
32%
Pancreas Adenocarcinoma
31%
Surgeon
30%
Gastric Bypass Surgery
30%
Gastric Bypass
30%
Pilonidal Cyst
30%
Endoscopic Retrograde Cholangiopancreatography
29%
Bariatric Surgery
28%
Transplantation
28%
Tricuspid Insufficiency
26%
Reoperation
25%
Elderly Patient
25%
Malignant Neoplasm
24%
Pancreas Cancer
24%
Metastatic Carcinoma
23%
Long Term Survival
22%
Colorectal Liver Metastasis
22%
Kidney Transplantation
21%
Inferior Vena Cava
21%
Surgical Anastomosis
21%
Colon Diverticulosis
20%
CA-125
20%
Common Bile Duct Stone
20%
Sinus Disease
20%
Pancreatic Incidentaloma
20%
Pancreas Islet Cell Tumor
20%
Intention-to-Treat Analysis
20%
Blood Clot
20%
Recurrence Risk
18%
Computer Assisted Tomography
17%
Liver Transplantation
17%
Pancreatic Surgery
17%
Trephine
16%
Crohn's Disease
16%
Echography
15%
Distal Pancreatectomy
15%
Surgical Approach
15%
Adenocarcinoma
14%
Platelet
14%
Pancreas Fistula
14%
Tumor Progression
13%
Glomerular Filtration Rate
13%
Arm
13%
Keyphrases
Pancreaticoduodenectomy
49%
Resection
44%
Postoperative Complications
41%
Tumor
40%
Liver Resection
40%
Tertiary Care Hospital
35%
Readmission
29%
Long-term Survival
28%
Liver Transplantation
27%
Reoperation
26%
Liver
26%
Elderly Patients
26%
Endoscopic Retrograde Cholangiopancreatography
26%
Retrospective Analysis
25%
Colorectal Liver Metastases
23%
Solid Pseudopapillary Tumor
23%
Risk Factors
22%
Inferior Vena Cava
21%
Body Mass Index
21%
Length of Hospital Stay
20%
Tricuspid Regurgitation
20%
Pancreatic Ductal Adenocarcinoma
20%
Nonfunctional Pancreatic Neuroendocrine Tumor
20%
Pancreatic Incidentaloma
20%
Borderline Resectable Pancreatic Cancer
20%
FOLFIRINOX
20%
Myeloid-derived Suppressor Cells
20%
Neoadjuvant
20%
Intention-to-treat Analysis
20%
One-anastomosis Gastric Bypass
20%
Colonic Diverticulitis
20%
Anatomic Liver Resection
20%
Pilonidal Disease
20%
Carbohydrate Antigen 125 (CA125)
20%
Surgical Approach
19%
Postoperative Mortality
19%
Patient Selection
19%
Patient Outcomes
19%
Bariatric Surgery
18%
Pancreatic Surgery
18%
Surgeons
17%
Tumor Growth
17%
Postoperative Outcomes
17%
Pancreatic Neuroendocrine Tumors (pNETs)
16%
Metastasis
16%
After Surgery
16%
Abdominal Pain
16%
Acute Diverticulitis
16%
Crohn's Disease
16%
Etiology
15%